Supplementary Table 1 from Randomized Phase II Study of Durvalumab with or Without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer
crossref(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined